Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL784611 | 0.79 | ALDH1A1 (0.34) | SMN1; SMN2KDM4E | |
| SCHEMBL15032497 | 0.76 | — | — | |
| SCHEMBL12206794 | 0.76 | ADORA2A (0.36) | SMN1; SMN2 | |
| SCHEMBL14769820 | 0.73 | ALDH1A1 (0.36) | SMN1; SMN2 | |
| SCHEMBL17282462 | 0.73 | KDM4E (0.33) | SMN1; SMN2KDM4E | |
| SCHEMBL21392460 | 0.71 | LMNA (0.33) | — | |
| SCHEMBL15468852 | 0.68 | ADORA2A (0.33) | — | |
| SCHEMBL12942479 | 0.67 | KDM5A (0.33) | SMN1; SMN2KDM4E | |
| SCHEMBL14769821 | 0.67 | MAPT (0.46) | KDM4E | |
| SCHEMBL18080597 | 0.66 | ADORA2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9403863-B2 | Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections | IDENIX PHARMACEUTICALS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-20130064794-A1 | Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections | IDENIX PHARMACEUTICALS, INC. (US) | 2013-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130064794-A1 | Substituted Carbonyloxymethylphosphoramidate Compounds and Pharmaceutical Compositions for the Treatment of Viral Infections | PYGL, HAVCR2, PNP | SMN1; SMN2 397/4885KDM4E 1453/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.